Replies to post #2353 on Skye Bioscience Inc (SKYE)

[AntonChigurh]

Well, Nemus has perpetual rights to a lot of UMiss IP and is their exclusive partner. Maybe that is why the partnership fell apart.

Can I get the links to the Elsohly interview you are referencing? How long ago was it?

[AntonChigurh]

Thanks to CJ for making me dig

http://www.alternet.org/story/141522/is_big_pharma_trying_to_take_all_the_fun_out_of_pot

Article dated 2009

NEMUS created in 2011 (I think) and public went late 2014/2015.

Would guess the time has come and gone for Mallin and ElSohly. Mallin makes Cesamet. I went to see what Cesamet was about, and found something interesting.

'Although Cesamet was initially approved by the FDA in 1985, it was later withdrawn from the market by then-manufacturer Eli Lilly for commercial reasons. The drug has been marketed as an anti-nauseant in Canada and the United Kingdom by Valeant Pharmaceuticals, which purchased the rights to Cesamet in 2004. According to the manufacturer, potential adverse reactions to the drug include ataxia (loss of ability to coordinate muscular movement), euphoria, headache, vertigo, increased heart rate, and concentration difficulties.'

Dr. Murphy was the CSO at Valeant 2003-2006 before Pearson showed up. Valeant acquired Cesamet in 2004.

I always thought Murphy was just a smart guy who saw an opportunity with cannibinoids, but didn't have any experience.

Vinpat, Has he been at this for longer than I thought?